1. & Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation 136(11), CIRCULATIONAHA.117.030583
  2. et. al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. New England Journal of Medicine 376(16), 1527-1539.
  3. et. al. Screening for Atrial Fibrillation. Circulation 135(19), 1851-1867.
  4. & Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open 7(9), e015363
  5. & Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis 264, 36-43.

See more...


  • PMCM01 Cardiovascular Medicine

    This module aims to explore the causes, risk factors and treatment of cardiovascular disease: the biggest cause of death in the UK. It will develop students¿ knowledge of the many key factors that contribute to this enormous healthcare issue. It will also demonstrate to students how each risk area is assessed and also the links between the individual risks.


  • Electronic record linkage cohort study of hrombotic and hemorrhagic events in patients with coronary heart disease and atrial fibrillation (current)

    Student name:
    Other supervisor: Prof Michael Gravenor